National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

danazol
A synthetic androgen derived from ethinyl testosterone. Danazol indirectly reduces estrogen production by decreasing pituitary secretion of follicle-stimulating hormone and luteinizing hormone, and binds to sex hormone receptors in target tissues, thereby exhibiting antiestrogenic, anabolic and weakly androgenic effects. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

US brand names:Danocrine
Winobanin
Foreign brand names:Bonzol
Chronogyn
Cyclomen
Danol
Danoval
Ladogal
Abbreviation:DAN
Code name:Win-17757
Chemical structure names:
  • (17alpha)-pregna-2,4-dien-20-yno[2,3-d]-isoxazol-17-ol
  • 17alpha-ethynyl-17beta-hydroxy-4-androsteno[2,3-d]isoxazole
  • 1-ethynyl-2,3,3a,3b,4,5,10,10a,10b,11,12,12a-dodecahydro-10a,12a-dimethyl-1H-cyclopental[7,8]phenanthro[3,2-d]isoxazol-1-ol



Previous:dacetuzumab, daclizumab, Dacogen, dactinomycin, dalteparin
Next:daniquidone, Danocrine, daptomycin, Daraprim, darbepoetin alfa

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov